Increased EpCAM levels are typical for epithelium-derived tumors, and EpCAM overexpression in tumor tissue has been associated with poor prognosis in breast, pancreatic, urothelial, and gallbladder carcinoma [14,15,16,17]. This evidence concerns the gene EPCAM and gallbladder carcinoma.